---
title: "SAN: Q2 2026 saw strong sales and profit growth, led by Dupixent and new launches"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294334114.md"
description: "Q2 2026 delivered robust double-digit sales and profit growth, driven by Dupixent and new launches, with upgraded 2026 and 2030 ambitions. Strategic pipeline decisions, cost discipline, and capital allocation support continued momentum.Original document: Sanofi SA [SAN] Slides Release — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T09:15:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294334114.md)
  - [en](https://longbridge.com/en/news/294334114.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294334114.md)
---

# SAN: Q2 2026 saw strong sales and profit growth, led by Dupixent and new launches

Q2 2026 delivered robust double-digit sales and profit growth, driven by Dupixent and new launches, with upgraded 2026 and 2030 ambitions. Strategic pipeline decisions, cost discipline, and capital allocation support continued momentum.

Original document: Sanofi SA \[SAN\] Slides Release — Jul. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [SNY.US](https://longbridge.com/en/quote/SNY.US.md)
- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)

## Related News & Research

- [Sanofi raises sales outlook on Dupixent strength in boost for new CEO](https://longbridge.com/en/news/294305951.md)
- [Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D](https://longbridge.com/en/news/294405008.md)
- [Sanofi Expects Moderate Increases In R&D Spend](https://longbridge.com/en/news/294368088.md)
- [ACOMO: Strong H1 results, resilient margins, and strategic growth despite global uncertainties](https://longbridge.com/en/news/294082652.md)
- [Regeneron publishes corporate presentation highlighting Q2 pipeline progress and product sales trends](https://longbridge.com/en/news/294365385.md)